| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |